DocuSign (DOCU) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

In the past month, DocuSign (DOCU) experienced a price decline of 9%. This movement contrasts with the broader performance of major market indices, which have recently reached record highs fueled by ...

DocuSign (DOCU) closed at $67.14 in the latest trading session, marking a -2.96% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.25% for the day. Meanwhile, ...

Docusign is a growth stock with 11% upside, driven by AI innovation and strong cash flow. Read more on key metrics and ...

An uninspiring quarterly earnings report and a clutch of analyst price target cuts put Docusign (NASDAQ: DOCU) stock in the market's doghouse in June. Before the first trading week of the month ...

Docusign's stock trades at 61 times forward earnings and 5 times this year's sales. Confluent can't be valued by its profits, but it trades at 7 times this year's sales.

Docusign stock was pricey when it peaked in 2021. Its price-to-sales (P/S) ratio surged to around 40, which wasn't sustainable without the rapid revenue growth from the pandemic era.

Docusign Price Performance Shares of DOCU stock opened at $80.39 on Tuesday. The firm has a market cap of $16.24 billion, a P/E ratio of 15.20, a P/E/G ratio of 29.81 and a beta of 1.08. The firm ...

DocuSign, Inc. (NASDAQ:DOCU) is one of the 11 stocks Jim Cramer put under the microscope recently. Answering a caller’s query about the company during the lightning round, Cramer stated: “You ...

Docusign (DOCU -1.87%) went public in 2018 at $29 per share, and by mid-2021, it had soared more than tenfold to a peak of $310. The COVID-19 pandemic drove incredible demand for the company's ...

However, Docusign's insiders sold nearly 2.1 million shares over the past 12 months while only buying around 1,300 shares. Confluent's insiders bought 17.2 million shares and sold 17.6 million ...

Docusign stock was pricey when it peaked in 2021. Its price-to-sales (P/S) ratio surged to around 40, which wasn't sustainable without the rapid revenue growth from the pandemic era.